The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
About this item
Full title
Author / Creator
Tanaka, Yoshiya , Soen, Satoshi , Hirata, Shintaro , Okada, Yosuke , Fujiwara, Saeko , Tanaka, Ikuko , Kitajima, Yuriko , Kubota, Takuo , Ebina, Kosuke , Takashi, Yuichi , Inoue, Reiko , Yamauchi, Mika , Okubo, Naoaki , Ueno, Masanobu , Ohata, Yasuhisa , Ito, Nobuaki , Ozono, Keiichi , Nakayama, Hisanori , Terauchi, Masakazu , Tanaka, Sakae and Fukumoto, Seiji
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Introduction
Although synthetic glucocorticoids (GCs) are commonly used to treat autoimmune and other diseases, GC induced osteoporosis (GIOP) which accounts for 25% of the adverse reactions, causes fractures in 30–50% of patients, and markedly decreases their quality of life. In 2014, the Japanese Society for Bone and Mineral Research (JSBMR) p...
Alternative Titles
Full title
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Authors, Artists and Contributors
Author / Creator
Soen, Satoshi
Hirata, Shintaro
Okada, Yosuke
Fujiwara, Saeko
Tanaka, Ikuko
Kitajima, Yuriko
Kubota, Takuo
Ebina, Kosuke
Takashi, Yuichi
Inoue, Reiko
Yamauchi, Mika
Okubo, Naoaki
Ueno, Masanobu
Ohata, Yasuhisa
Ito, Nobuaki
Ozono, Keiichi
Nakayama, Hisanori
Terauchi, Masakazu
Tanaka, Sakae
Fukumoto, Seiji
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3020649686
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3020649686
Other Identifiers
ISSN
0914-8779,1435-5604
E-ISSN
1435-5604
DOI
10.1007/s00774-024-01502-w
